Online consultations open for 68 days
OTTAWA, May 7, 2018 /CNW/ - Many Canadians with life-threatening illnesseswish to remain independent and receive the care they need in the setting of their choice. Improving access to palliative care in a variety of settings, including at home, is critical to making this happen.
Today, Health Canada launched a public
This consultation complements the leadership role taken by the federal government in engaging with provinces and territories through the Common Statement of Principles on Shared Health Priorities and its commitment to improve access to home, community, and palliative care by providing $6 billion over 10 years to support these goals. Improved access to home, community and palliative care will help to reduce the number of patients in hospital who would prefer to be supported and cared for at home.
In the coming months, the federal government will consult directly with provinces, territories, palliative care providers, people living with illness, caregivers, and other expert stakeholders. The comments received during these consultations will help inform the development of the framework for palliative care, which will be tabled in Parliament by December 13, 2018.
The Government of Canada looks forward to working cooperatively with provincial and territorial governments and stakeholders at all levels to help support improvements in the quality and availability of palliative care for Canadians.
"Canadians who need palliative care should have access to these services when they need them, in the setting of their choice. We look forward to hearing views from across the country as we develop a framework that will help support improved access to palliative care in Canada."
The Honourable Ginette Petitpas TaylorMinister of Health
Associated Links Palliative care Framework on Palliative Care in Canada Act Participate in the consultation
SOURCE Health Canada
Subscribe to our Free Newsletters!
Collagen plays a crucial role in glowing skin, strong nails and shiny hair. You can boost collagen ...
CRISPR technology is a simple but potent tool for editing any part of the genome (complete set of ...
FDA recently approved Mogamulizumab-kpkc, a human monoclonal antibody prescribed for adult ...View All